Summary
B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative spine surgery, neurosurgery, diabetes, nutrition therapy, general open surgery, orthopedic joint replacement, hemodialysis, pain therapy, incontinence, stoma, infection prevention, and wound management. It has manufacturing facilities and R&D centers in the US, Europe and Asia. The company sells its products through a network of subsidiaries and associated companies in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.
B. Braun Melsungen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
Acquisition 15
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG - Key Competitors 23
B. Braun Melsungen AG - Key Employees 24
B. Braun Melsungen AG - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 29
Recent Developments 30
Financial Announcements 30
Mar 31, 2017: B. Braun continues its sales and earnings growth 30
Mar 23, 2016: B. Braun's growth trend continues 32
Corporate Communications 34
Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 34
Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 35
Feb 22, 2017: Change in the B. Braun Management Board 36
Oct 05, 2016: B. Braun Supports The International Safety Center 37
Other Significant Developments 38
Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 38
Feb 15, 2017: B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Tables
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG, Key Competitors 23
B. Braun Melsungen AG, Key Employees 24
B. Braun Melsungen AG, Other Locations 25
B. Braun Melsungen AG, Subsidiaries 25
B. Braun Melsungen AG, Joint Venture 29
List of Figures
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
